SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Geron to Present at Upcoming Investor Conferences in November
[November 07, 2018]

Geron to Present at Upcoming Investor Conferences in November


MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present a company overview at the following investor conferences:

  • Stifel 2018 Healthcare Conference in New York at 2:00 p.m. ET on Wednesday, November 14, 2018
  • 30th Annual Piper Jaffray Healthcare Conference in New York at 11:30 a.m. ET on Tuesday, November 27, 2018


    • A live audio webcast of each presentation will be available on Geron’s website, www.geron.com/investors/events. If you are unable to listen to the live presentations, an archived webcast of each presentation will be available on the Company’s website for 30 days.

      About Geron


      Geron is a clinical stage biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

      CONTACT:

      Suzanne Messere
      Investor and Media Relations
      investor@geron.com
      media@geron.com

      CG Capital
      877-889-1972

      Geron-logo-black-xsmall.png


      [ Back To TMCnet.com's Homepage ]







Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy